This incident occurred in japan.Plasmaflo op-d series is identical model to op-05w(a) marketed in us.Patient with chronic inflammatory demyelinating polyradiculoneuropathy received simple plasma exchange treatments using op-08d.Albumin was used as replacement fluid.Five minutes after the 5th treatment on (b)(6) 2023, urticaria developed throughout the body and treatment was discontinued.Drug allergy was suspected, and loxoprofen sodium hydrate and nafamostat mesilate were discontinued.After discontinuing treatment, steroid was administered via iv, but it was discontinued due to severe drowsiness.About 15 minutes after the start of the 6th treatment on (b)(6) 2023, urticaria also appeared all over the body, but the treatment was continued.At the time of this treatment, no drug was used.Patient's symptom was improved after completion of treatment.
|